Heyman Richard A. sold ORIC
July 24, 2026 · Form 4 insider transaction
Heyman Richard A. sold 7,000 shares of ORIC Pharmaceuticals, Inc. at $12.02 per share, a transaction worth $84.1K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
7,000
Price
$12.02
Total value
$84.1K
InsiderHeyman Richard A.
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJuly 24, 2026
Filing dateJuly 28, 2026
Shares owned after38,300
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and RAHD Capital, LLC.